Dr Dev Banerjee - Professional Biography

Current Roles

  1. Staff Specialist in Sleep Medicine and Medical Director at Woolcock Institute of Medical Research, Glebe, Sydney and Clinical Committee chair and Executive Board member Woolcock Institute
  2. Respiratory and Sleep Medicine Staff specialist at St Vincents Hospital; lead for respiratory non invasive ventilation services and senior specialist sleep disorder service, Heart and Lung Program.


  1. BSc Hons Physiology 2:1Leeds University 1989          
  2. Bachelor in Medicine and Surgery Degree MB ChBLeeds University 1992     
  3. Intensive Care Medicine Training Intermediate level attained 1995
  4. Intercollegiate Board of Intensive Care Medicine Royal College of Anaesthesia UK 1998
  5. Certificate of Completion of Specialist Training (CCST) General Internal Medicine and Respiratory Medicine 2002   
  6. Doctorate of Medicine (MD) University of Birmingham 2003
  7. Fellow of the Royal College of Physicians FRCP UK Royal College of Physicians 2008
  8. Accreditation in Sleep Medicine: European Sleep Research Society (ESRS) 2012          
  9. Fellow of the Royal Australasian College of Physicians FRACP Australia Respiratory and Sleep Medicine 2013            


Staff Specialist Level UK March 2004 to Aug 2013

Consultant in Sleep Medicine / Ventilation and Respiratory Physician Birmingham Heartlands Hospital (2004 - 2013)

Clinical and Research Lead in Sleep Birmingham Heartlands Hospital (2004 - 2013) Director of NIV working group (2004 – 2010)

Co-director, Centre for Sleep and Metabolism Heartland Biomedical research centre (2009-2011)

Senior Research Fellow, Sleep Medicine Aston University, Aston Brain Centre, School of

Health and Life Sciences, Birmingham (2009- 2013)

Honorary Senior Lecturer, University of Birmingham (2004 - 2013)

Honorary Associate Professor, University of Warwick (2008- 2009)

Secretary, Midlands Thoracic Society (2007 - 2013)

Honorary Consultant in Paediatric and Adolescent Sleep medicine Birmingham Childrens hospital (2012 – 2013)

 Other Current Roles

Medical Council of NSW – Council Appointed Practitioner (CAP) assessing work performance issues in doctors with sleep disorders (2014 – present)

NSW and Victoria Police and Public Prosecution– medico legal expert(2014 – present)

Honorary Associate University of Sydney

Conjoint Senior Lecturer University of New South Wales



Banerjee D, Sukumar N, Ryder REJ, Mir MA, Freeman EA. An Aid to the MRCP PACES 4th edition. Volume 2: Stations 2 and 4. 2013. Wiley-Blackwell Publishing. ISBN 978-0-470-65518-4

Book chapters

Choudhury S, Thomas A, Taheri S Banerjee D. Sleepiness and driving. Encyclopedia of Sleep and Dreams: the evolution , Function, Nature and Mysteries of Slumber. Ed BarrettD and McNamara P. Greenwood California, Colorado, Oxford June 2012 ISBN 0213386641

Banerjee D. Obstructive sleep apnoea – medical management. Scott-Brown’s Otorlaryngology: 7th Edition. Hodder & Stoughton (2008). 8th in preparation.

Original Research

Dave C, Turner A, Thomas A, Beauchamp B, Chakraborty B, Ali A, Mukherjee R, Banerjee D. Utility of respiratory ward-based NIV in acidotic hypercapnic respiratory failure. Respirology. 2014 Nov;19(8):1241-7

Leong WB, Nolen M, Thomas GN, Adab P, Banerjee D, Taheri S. The impact of hypoxemia on nephropathy in extremely obese patients with type 2 diabetes mellitus. J Clin Sleep Med. 2014 Jul 15;10(7):773-8. PMID:25024655

Leong WB, Banerjee D, Nolen M, Adab P, Thomas GN, Taheri S. Hypoxemia and glycemic control in type 2 diabetes mellitus with extreme obesity.J Clin Endocrinol Metab. 2014 Sep;99(9):E1650-4. PMID:24937534

Banerjee D, Leong WB, Arora T, Nolen M, Punamiya V, Grunstein R, Taheri S. The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity – the role of hypoxemia. PLoS One. 2013 Nov 18; 8(11): e79521.  PMID 24260240

Leong WB, Arora T, Jenkinson D, Thomas A, Puniamaya V, Banerjee D, Taheri S. The prevalence and severity of obstructive sleep apnea in severe obesity: the impact of ethnicity. J Clin Sleep Med 2013; 9(9): 853-858. PMID 23997696

Phillips CL, Yee BJ, Trenell MI, Magnussen JS , Wang D, Banerjee D, Berend N, Grunstein RR. Changesinregionaladiposityandcardio-metabolicfunctionfollowingsibutramineassisted weight loss in obese men with Obstructive Sleep Apnea: Metabolic effects of weight loss in men with OSA. J Clin Sleep Med. 2009 Oct 15;5(5):416-21. PMID 19961024

Yee BJ, Buchanan PR, Mahadev S, Banerjee D, Liu PY, Phillips C, Loughnan G, Steinbeck K, Grunstein RR.Assessment of sleep and breathing in adults with prader-willi syndrome: a case control series. J Clin Sleep Med. 2007 Dec 15;3(7):713-8 PMID 17565018

Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007 Jun;131(6):1678-84. PMID17565018

YeeBJ,  PhillipsCL,  BanerjeeD,  CatersonI,  HednerJA,  GrunsteinRR.  Theeffectof sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes (Lond). 2007Jan;31(1):161-8. PMID 16652122

Yee B, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. The treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006;73(2):209-12. 16179823

Banerjee D, Khair OA, Honeybourne. The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. Resp Med 2005; 99: 208 - 21

Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004; 23(5): 685 – 691

Banerjee D, Honeybourne D, Khair OA. The effect of oral clarithromycin on bronchial airway inflammation in moderate to severe stable COPD: a randomised controlled trial. Treat Respir Med 2004; 3(1): 59 - 65

Banerjee D, Stanley P. Malaria chemoprophylaxis in UK General Practitioners travelling to South Asia. J Trav Med 2001; 8: 173 - 175

Honeybourne D, Banerjee D, Andrews J, Wise P. Concentrations of gatifloxacin in plasma and pulmonary compartments in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 2001; 48 (1): 63 – 66

Andrews JM, Honeybourne D, Banerjee D, Iredale M, Cunningham B, Wise R. Concentrations of Trovafloxacin (CP.99.219) in bronchial mucosa epithelial lining fluid, alveolar macrophages and serum after administration ofsingleor multipleoral doses to patients undergoing fibreoptic bronchoscopy. J Antimicrob Chemother 1997; 39(6):797 – 802

Review Articles

Pallayova M, Banerjee D, Taheri S. Novel insights into metabolic sequelae of obstructive sleep apnoea: A link between hypoxic stress and chronic diabetes complications. Diabetes Res Clin Pract. 2014 May; 104(2): 197-205. PMID 24485855

Marzieh HA, Chen Y-F, Jagielski A, Choudhury S, Banerjee D, Thomas N, Taheri S, Effectiveness of Lifestyle Interventions on Obstructive Sleep Apnea (OSA): Systematic Review and Meta-Analysis. Sleep 2013; 36(10): 1553-62. PMID 21138944

Banerjee D and Nisbett A. Sleepwalking. Sleep Medicine Clinics 2011 vol6:4; 401-416

Banerjee D Sleep, work and health : part 1 – The impact of work on sleep. Occupational Health at Work 2011; 7(5): 15-18

Banerjee D Sleep, work and health : part 2 – obstructive sleep apnoea and the workplace – the impact on road safety. Occupational Health at Work 2011; 7(6): 16-18

Banerjee D. The Epworth Sleepiness scale. 2007 Occ Med; 57: 232

Grunstein RR, Banerjee D. The case of "judge nodd" and other sleeping judges--media, society, and judicial sleepiness. Sleep. 2007 May 1;30(5):625-32. PMID 17552378

Banerjee D, Vitiello MV, Grunstein RR. Pharmacotherapy for excessive daytime sleepiness. Sleep Med Rev 2004; 8(5): 339 – 354 PMID 15336235

Banerjee D, Honeybourne D. Chlamydia pneumoniae. CPD Infection 2002; 3: 54-58

Banerjee D, Honeybourne D. Chlamydia pneumoniae. Bugs & Drugs 2001; 7(2): 4 – 5

BanerjeeD,  StableforthDE.  ThetreatmentofrespiratoryPseudomonasinfectionincystic fibrosis – what drug and which way? Drugs 2000; 60(5): 1053 – 64

Banerjee D, Honeybourne D. The   role of fluoroquinolones in Chronic Obstructive Pulmonary

Disease. Curr Opin Infect Dis 1999; 12: 543 – 547

Banerjee D, Honeybourne D.   Drug-induced Pulmonary alveolar disease – a review. Adverse

Drug React Bull 1997; 181: 687 – 690

Case Reports

Jose B, Ali A, Begum S, Banerjee D, Taheri S. Obstructive sleep apnoea as a cause of headache presenting to the emergency department. QJM. 2011;104(12):1087-09

Banerjee D, Clamp A, D E Stableforth. A political asylum seeker with an amoebic empyema in Birmingham. Hosp Med 2001; 62(6): 372 -373

Banerjee D, Makker H, Iles P. Metastatic renal cell carcinoma mimicking a pleural mesothelioma. Resp Dis Pract 2000; 17(3): 18-19

Swinburn J, Ali S, Banerjee D, Khan Z. Discontinuation of ventilation after brain stem death – to whom is our duty of care? BMJ 1999; 318: 1753 – 1755

Letter to the Editor

Pressman MR, Mahowald M, Schenck C, Bornemann MC, Banerjee D, Howell M, Buchanan P, Avidan A. Spectral EEG analysis and sleepwalking defense: unreliable scientific evidence. J Clin Sleep Med. 2014 Jan 15; 10(1): 111-2

Pressman M, Mahowald MW, Schenck CH, Cramer -Bornemann MA, Banerjee D, Buchanan P, Zadra A. Alcohol, Sleepwalking and violence: lack of reliable scientific evidence. Brain 2013: 136 (Pt 2):e229

Walters G, James A, Gill S, Banerjee D. Airline acceptability of CPAP: is relevant information available on the airlines’ websites? Primary Care Resp J 2010; 19(1):87-88

Banerjee D, Yee B, Grunstein R. Airline acceptability of in-flight CPAP machines – Flight, Fright, or Fight? Sleep 2003; 26(7): 914 – 915. PMID 14655929

Banerjee D, O’DeaJ. Anaesthetists will continue to play a majorrole in themanagement of UK Intensive Care. Anaesthesia 2000; 55: 302

Banerjee D, Fraise A, Chana K. Writing pens are an unlikely vector of cross-infection with

Methicillin Resistant Staphylococcus aureus(MRSA). J Hosp Infect 1999; 1(2): 73 - 75


  1. Australasian Sleep Association
  2. American Academy of Sleep Medicine
  3. Expert Witness Institute UK
  4. Society of Expert Witnesses UK